1. 350 EFFECTS OF EXERCISE TRAINING AFTER ESOPHAGECTOMY ON PHYSICAL FITNESS, QUALITY OF LIFE AND TREATMENT OUTCOMES. (14th September 2020) Authors: Simonsen, C; Thorsen-Streit, S; Sundberg, A; Sigmundsdóttir Djurhuus, S; Ehlers Mortensen, C; Qvortrup, C; Klarlund Pedersen, B; Svendsen, L; de Heer, P; Frank Christensen, J Journal: Diseases of the esophagus Issue: Volume 33(2020)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 455PDNORDIC9: A randomized phase II trial comparing first-line palliative full-dose monotherapy (S-1) with reduced dose-combination therapy (SOx) in older and frail patients with metastatic colorectal cancer (mCRC). (23rd October 2018) Authors: Winther, S B; Skuladottir, H; Hofsli, E; Shah, C-H; Yilmaz, M K; Österlund, P J; Berglund, Å; Glimelius, B; Qvortrup, C; Sorbye, H; Pfeiffer, P Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of high-intensity exercise training on physical fitness, quality of life and treatment outcomes after oesophagectomy for cancer of the gastro-oesophageal junction: PRESET pilot study. Issue 5 (28th August 2020) Authors: Simonsen, C; Thorsen-Streit, S; Sundberg, A; Djurhuus, S S; Mortensen, C E; Qvortrup, C; Pedersen, B K; Svendsen, L B; Heer, P; Christensen, J F Journal: BJS open Issue: Volume 4:Issue 5(2020) Page Start: 855 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. O-014Bevacizumab improves efficacy of trifluridine/tipiracil (TAS-102) in patients with chemorefractory metastatic colorectal cancer: a Danish randomized trial. (2nd July 2019) Authors: Pfeiffer, P; Yilmaz, M; Möller, S; Zitnjak, D; Maltha, L; Krogh, M; Winther, S; Petersen, L; Hejlersen, F; Thomsen, K; Qvortrup, C Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. O-015Randomised trial of cetuximab every 2 weeks with FOLFIRI or cetuximab with alternating FOLFIRI/FOLFOX in patients with RAS and BRAF wild type metastatic colorectal cancer: Nordic 8 results. (2nd July 2019) Authors: Pfeiffer, P; Glimelius, B; Winther, S; Qvortrup, C; Yilmaz, M; Berglund, À; Vistisen, K; Kersten, C; Liposits, G; Sorbye, H Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗